罗恩 |
R029688-50mg |
50mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
2,876.00
2,876.00
|
|
罗恩 |
R029688-5mg |
5mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
457.00
457.00
|
|
罗恩 |
R029688-10mg |
10mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
733.00
733.00
|
|
阿拉丁 |
L129343-5mg |
5mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
Moligand™, ≥98% |
380.90
380.90
|
|
阿拉丁 |
L129343-10mg |
10mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
Moligand™, ≥98% |
610.90
610.90
|
|
阿拉丁 |
L129343-50mg |
50mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
Moligand™, ≥98% |
2,396.90
2,396.90
|
|
阿拉丁 |
L423823-1ml |
1ml |
现货 |
396129-53-6 |
LY364947 LY364947 |
Moligand™, 2mM in DMSO |
308.90
308.90
|
|
韶远 |
SY062841-1g |
1g |
现货 |
396129-53-6 |
4-[3-(2-吡啶基)-4-吡唑基]喹啉 4-[3-(2-Pyridyl)-4-pyrazolyl... |
≥95% |
3,133.00
3,133.00
|
|
毕得 |
BD136899-50mg |
50mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
322.00
322.00
|
|
毕得 |
BD136899-1g |
1g |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
2,691.00
2,691.00
|
|
毕得 |
BD136899-100mg |
100mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
548.00
548.00
|
|
毕得 |
BD136899-250mg |
250mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
996.00
996.00
|
|
梯希爱 |
L0476-25MG |
25MG |
现货 |
396129-53-6 |
4-[5-(2-吡啶基)-1H-吡唑-4-基]喹啉 LY-364947 |
95.0% |
990.00
990.00
|
|
麦克林 |
L860932-10mg |
10mg |
有货,货期请咨询 |
396129-53-6 |
LY-364947,HTS 466284 LY-364947,HTS 466284 |
>98% |
678.00
678.00
|
|